These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18159905)

  • 21. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
    Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 23. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.
    Fichel F; Barbe C; Joly P; Bedane C; Vabres P; Truchetet F; Aubin F; Michel C; Jegou J; Grange F; Antonicelli F; Bernard P
    JAMA Dermatol; 2014 Jan; 150(1):25-33. PubMed ID: 24226428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blistering insights into the pathogenesis of bullous pemphigoid.
    Wong HK; Bechtel MA
    Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
    [No Abstract]   [Full Text] [Related]  

  • 26. Vesicular pemphigoid with circulating autoantibodies against 230-kDa and 180-kDa proteins, and additional autoantibodies against 97-kDa and 45-kDa proteins.
    Lai FJ; Sheu HM; Lee JY; Cheng CL; Chen W
    Int J Dermatol; 2007 Feb; 46(2):206-9. PubMed ID: 17269979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
    Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
    Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological studies in bullous pemphigoid: a literature review of antibody titers at presentation and in clinical remission.
    Leuci S; Gürcan HM; Ahmed AR
    Acta Derm Venereol; 2010 Mar; 90(2):115-21. PubMed ID: 20169293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plectin, an unusual target antigen in bullous pemphigoid.
    Laffitte E; Favre B; Fontao L; Riou S; Jaunin F; Tamm K; Saurat JH; Borradori L
    Br J Dermatol; 2001 Jan; 144(1):136-8. PubMed ID: 11167694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
    Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
    J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bullous pemphigoid: from the clinic to the bench.
    Di Zenzo G; Della Torre R; Zambruno G; Borradori L
    Clin Dermatol; 2012; 30(1):3-16. PubMed ID: 22137222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of pemphigoid gestationis with concurrent IgG antibodies to BP180, BP230 and type VII collagen.
    Yang B; Wang C; Wu M; Du D; Yan X; Zhou G; Zhang F
    Australas J Dermatol; 2014 Feb; 55(1):e15-8. PubMed ID: 23082779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Amo Y; Ohkawa T; Tatsuta M; Hamada Y; Fujimura T; Katsuoka K; Hashimoto T
    J Dermatol Sci; 2001 May; 26(1):14-8. PubMed ID: 11323216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bullous pemphigoid].
    Ohyama M; Amagai M
    Ryoikibetsu Shokogun Shirizu; 2000; (31):274-6. PubMed ID: 11269078
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid.
    Esmaili N; Mortazavi H; Kamyab-Hesari K; Aghazadeh N; Daneshpazhooh M; Khani S; Chams-Davatchi C
    Clin Exp Dermatol; 2015 Apr; 40(3):324-30. PubMed ID: 25476471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological predictors shared by dementia and bullous pemphigoid patients point out a cross-antigenicity between BP180/BP230 brain and skin isoforms.
    Julio TA; Vernal S; Massaro JD; Silva MC; Donadi EA; Moriguti JC; Roselino AM
    Immunol Res; 2018 Oct; 66(5):567-576. PubMed ID: 30220011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
    Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
    Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.